BWX Technologies holder plans sale of 10,000 shares

A stockholder of BWX Technologies, Inc. filed a notice of proposed sale of 10,000 common shares under Rule 144.

Rhea-AI Filing Summary

A stockholder of BWX Technologies, Inc. filed a notice of proposed sale of 10,000 common shares under Rule 144.

The shares are expected to be sold through Charles Schwab & Co., Inc. on the NYSE around 02/12/2026, with an aggregate market value of $2,032,560.

The filing notes that 91,426,744 shares of the issuer were outstanding and that the seller acquired these shares via RSU and RSU/PSU equity compensation grants in 2023 and 2024. During the past three months, 10,000 shares were sold for $1,979,005.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BWXT Form 144 filing disclose?

The Form 144 discloses a stockholder’s intention to sell 10,000 BWX Technologies, Inc. common shares under Rule 144. The proposed sale is through Charles Schwab & Co., Inc. on the NYSE, with an indicated aggregate market value of $2,032,560.

How many BWX Technologies (BWXT) shares are proposed to be sold?

The notice covers a proposed sale of 10,000 BWX Technologies, Inc. common shares. This amount is listed in the securities information table and is tied to an aggregate market value entry of $2,032,560 for the planned Rule 144 transaction.

When is the planned Rule 144 sale for BWXT shares expected?

The planned sale is targeted for approximately 02/12/2026. That approximate date of sale is shown in the securities information table, alongside details of the 10,000 common shares, the broker Charles Schwab & Co., Inc., and the NYSE as the named exchange.

How were the BWXT shares in this Form 144 acquired?

The shares were acquired through equity compensation awards. The table shows RSU grants dated 02/18/2024 and RSU/PSU grants dated 02/27/2023 from BWX Technologies, Inc., totaling 609 and 9,391 securities respectively, both labeled as equity compensation payments.

What prior BWXT share sales are disclosed in the last 3 months?

The filing lists a sale by Rex D Geveden of 10,000 BWX Technologies, Inc. securities on 11/12/2025. The gross proceeds from that transaction were $1,979,005, and this is reported in the section covering securities sold during the past three months.

How many BWX Technologies (BWXT) shares are outstanding in this filing?

The securities information table reports 91,426,744 BWX Technologies, Inc. shares outstanding. This figure provides context for the 10,000-share proposed Rule 144 sale, indicating the issuer’s total share count referenced in connection with the planned transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001408482
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BWX Technologies, Inc.
SEC File Number	001-34658
Address of Issuer	800 MAIN STREET 4TH FLOOR LYNCHBURG VIRGINIA 24504
Phone	980-365-4300
Name of Person for Whose Account the Securities are To Be Sold	Geveden Rex D
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	10000	2032560.00	91426744	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/18/2024	RSU	BWX Technologies, Inc.			609	02/18/2024	Equity Compensation
Common	02/27/2023	RSU / PSU	BWX Technologies, Inc.			9391	02/27/2023	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
REX D GEVEDEN 800 MAIN STREET 4TH FLOOR LYNCHBURG VA 24504	BWX Technologies, Inc.	11/12/2025	10000	1979005.00

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	REX D GEVEDEN
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)